ENTITY

Respiri Ltd (RSH AU)

25
Analysis
Health CareAustralia
Respiri Limited develops and commercializes medical devices. The Company offers wheeze detection devices, inhalers, acoustic sensors, and electronic asthma diaries. as well as renders smartphone applications to detect and measure wheezing and coughing problems. Respiri serves customers worldwide.
more
bullishRespiri Ltd
14 Dec 2022 15:30Issuer-paid

Respiri - Shorter pilot study, potentially faster roll-out

Respiri continues to advance its commercialisation plans for wheezo with the recent initiation of patient onboarding for the Minnesota Lung...

Share
bullishRespiri Ltd
07 Dec 2022 16:32Issuer-paid

Respiri - First primary care setting client win

Respiri has announced another client win, this time in a primary care setting for remote patient monitoring (RPM) services using its wheezo device....

Share
bullishRespiri Ltd
28 Nov 2022 23:16Issuer-paid

Respiri - Commercialization efforts gathering steam

The Respiri/Access Telehealth collaboration continues to make steady gains in the US with the partners announcing their fourth commercial deal to...

Share
bullishRespiri Ltd
18 Nov 2022 19:56Issuer-paid

Respiri - Wheezo bags third client win in the US

Respiri continues to expand its commercial footprint in the United States with the signing of another client account, with Minnesota Lung Center...

Share
bullishRespiri Ltd
08 Nov 2022 15:31Issuer-paid

Respiri - First patient enrolled in the US RPM programme

Respiri has announced that the first patients have been enrolled in its wheezo remote patient monitoring (RPM) programme in the United States....

Share
x